Kemin has achieved a significant milestone with the Thailand Food and Drug Administration (TFDA), granting approval for its immune health ingredient, BetaVia Complete, thereby awarding it the prestigious Novel Food status. This breakthrough allows the utilization of the beta-glucan ingredient, sourced from algae, Euglena gracilis, in human food supplements within Thailand, with a recommended daily dose of 375 mg. Notably, BetaVia Complete is acclaimed for its remarkable content of beta-1,3-glucan, essential fatty acids, and protein, and has already obtained approvals in both the United States and the European Union. Its manifold benefits encompass fortifying the body’s natural defense mechanisms, supporting the health of the respiratory tract, and safeguarding the integrity of the intestinal barrier.
The approval from the TFDA marks a significant stride for Kemin, as it opens doors for the application of BetaVia Complete in food supplements targeted at enhancing human immune health within the country. Now, with this latest approval, BetaVia Complete can further its global reach and bring its valuable contributions to the people of Thailand, supporting their well-being by reinforcing their natural immune defenses, promoting respiratory tract health, and protecting the vital intestinal barrier.
The versatility and efficacy of BetaVia Complete have been recognized through multiple approvals in different regions, attesting to its profound potential in bolstering human health. As Kemin continues to innovate in the field of immune health ingredients, the company’s dedication to enhancing wellness remains evident. The newfound approval from the TFDA solidifies BetaVia Complete’s position as a valuable asset in the pursuit of better health and well-being world-wide.
